statistiche ricercatore

Continente	#
NA - Nord America	419
AS - Asia	211
EU - Europa	181
SA - Sud America	47
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	10
Totale	890

Città	#
Dublin	56
Chandler	50
San Jose	47
Ashburn	43
Beijing	29
Singapore	29
Dallas	28
Hong Kong	25
Los Angeles	16
Council Bluffs	15
Helsinki	12
Boardman	10
Ho Chi Minh City	10
Munich	9
Johannesburg	8
Brno	7
Buffalo	7
Lauterbourg	7
Lawrence	7
Medford	7
Princeton	7
Hanoi	6
Wilmington	6
New York	5
Santa Clara	5
Shanghai	5
São Paulo	5
Atlanta	4
Giessen	4
Moscow	4
Piscataway	4
Tokyo	4
Columbus	3
Guangzhou	3
Hải Dương	3
Newark	3
Orem	3
Stockholm	3
Turku	3
Warsaw	3
Washington	3
Boston	2
Brooklyn	2
Da Nang	2
El Paso	2
Houston	2
Lahore	2
London	2
Manchester	2
Montreal	2
Nanchang	2
Norwalk	2
Ostiglia	2
Redondo Beach	2
San Salvador	2
Shenyang	2
The Dalles	2
Vũng Tàu	2
Addis Ababa	1
Almere Stad	1
Ambrolauri	1
Amman	1
Andover	1
Ankara	1
Ann Arbor	1
Antakya	1
Athens	1
Bayrampaşa	1
Bengaluru	1
Bhubaneswar	1
Birigui	1
Bishkek	1
Brasília	1
Bridgetown	1
Buenos Aires	1
Bytom	1
Bắc Ninh	1
Cairo	1
Caldas Novas	1
Calgary	1
Campinas	1
Can Tho	1
Caruaru	1
Casamassima	1
Catania	1
Caxias do Sul	1
Changsha	1
Chicago	1
Colina São Pedro dos Morrinhos	1
Colombo	1
Cranston	1
Curitiba	1
Dakar	1
Dawsonville	1
DeSoto	1
Dearborn	1
Delhi	1
Denver	1
Dhaka	1
Düsseldorf	1
Totale	584

Nome	#
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells	156
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease	140
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease	125
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease	114
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects	107
Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease	96
Single or combined treatment with l-DOPA and quinpirole differentially modulate expression and phosphorylation of key regulatory kinases in neuroblastoma cells	89
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease	63
Totale	890

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	34	0	0	0	0	0	0	2	2	4	1	4	21
2022/2023	128	14	15	0	11	8	11	0	5	60	0	3	1
2023/2024	70	7	14	2	2	7	20	0	3	0	1	9	5
2024/2025	186	12	8	9	3	7	13	10	14	42	13	21	34
2025/2026	351	30	25	34	50	53	12	57	17	37	29	3	4
2026/2027	94	7	21	23	19	24	0	0	0	0	0	0	0
Totale													890